Association of Pneumococcal Serotype With Susceptibility to Antimicrobial Drugs: A Systematic Review and Meta-analysis

被引:7
作者
Andrejko, Kristin [1 ]
Ratnasiri, Buddhika [2 ]
Lewnard, Joseph A. [3 ,4 ]
机构
[1] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA USA
[2] Univ Calif Berkeley, Coll Letters & Sci, Berkeley, CA USA
[3] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA USA
[4] Univ Calif Berkeley, Coll Engn, Ctr Computat Biol, Berkeley, CA USA
关键词
antimicrobial resistance; pneumococcal conjugate vaccine; serotype; Streptococcus pneumoniae; STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; YOUNG-CHILDREN; CARRIAGE; DISEASE; SURVEILLANCE; RESISTANCE; DURATION; EFFICACY; PROGRAM;
D O I
10.1093/cid/ciab852
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Pneumococcal serotypes differ in antimicrobial susceptibility. However, patterns and causes of this variation are not comprehensively understood. Methods We undertook a systematic review of epidemiologic studies of pneumococci isolated from carriage or invasive disease among children globally from 2000-2019. We evaluated associations of each serotype with nonsusceptibility to penicillin, macrolides, and trimethoprim/sulfamethoxazole. We evaluated differences in the prevalence of nonsusceptibility to major antibiotic classes across serotypes using random-effects meta-regression models and assessed changes in prevalence of nonsusceptibility after implementation of pneumococcal conjugate vaccines (PCVs). We also evaluated associations between biological characteristics of serotypes and their likelihood of nonsusceptibility to each drug. Results We included data from 129 studies representing 32 187 isolates across 52 countries. Within serotypes, the proportion of nonsusceptible isolates varied geographically and over time, in settings using and those not using PCVs. Factors predicting enhanced fitness of serotypes in colonization as well as enhanced pathogenicity were each associated with higher likelihood of nonsusceptibility to penicillin, macrolides, and trimethoprim/sulfamethoxazole. Increases in prevalence of nonsusceptibility following PCV implementation were evident among non-PCV serotypes, including 6A, 6C, 15A, 15B/C, 19A, and 35B; however, this pattern was not universally evident among non-PCV serotypes. Postvaccination increases in nonsusceptibility for serotypes 6A and 19A were attenuated in settings that implemented PCV13. Conclusions In pneumococci, nonsusceptibility to penicillin, macrolides, and trimethoprim/sulfamethoxazole is associated with more frequent opportunities for antibiotic exposure during both prolonged carriage episodes and when serotypes cause disease. These findings suggest multiple pathways leading to resistance selection in pneumococci. Serotypes with greater capacity to persist in the upper respiratory tract and to cause disease were each more likely to exhibit antimicrobial nonsusceptibility. Amid PCV implementation, nonsusceptibility to antimicrobial drugs increased among non-PCV serotypes associated with upper respiratory tract carriage.
引用
收藏
页码:131 / 140
页数:10
相关论文
共 40 条
  • [1] Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes
    Albrich, WC
    Monnet, DL
    Harbarth, S
    [J]. EMERGING INFECTIOUS DISEASES, 2004, 10 (03) : 514 - 517
  • [2] Antimicrobial resistance in paediatric Streptococcus pneumoniae isolates amid global implementation of pneumococcal conjugate vaccines: a systematic review and meta-regression analysis
    Andrejko, Kristin
    Ratnasiri, Buddhika
    Hausdorff, William P.
    Laxminarayan, Ramanan
    Lewnard, Joseph A.
    [J]. LANCET MICROBE, 2021, 2 (09): : E450 - E460
  • [3] [Anonymous], 2014, Revised WHO Classification and Treatment of Pneumonia in Children at Health Facilities: Evidence Summaries
  • [4] Fitting Linear Mixed-Effects Models Using lme4
    Bates, Douglas
    Maechler, Martin
    Bolker, Benjamin M.
    Walker, Steven C.
    [J]. JOURNAL OF STATISTICAL SOFTWARE, 2015, 67 (01): : 1 - 48
  • [5] Post-13-Valent Pneumococcal Conjugate Vaccine Dynamics in Young Children of Serotypes Included in Candidate Extended-Spectrum Conjugate Vaccines
    Ben-Shimol, Shalom
    Givon-Lavi, Noga
    Kotler, Leore
    van der Beek, Bart Adriaan
    Greenberg, David
    Dagan, Ron
    [J]. EMERGING INFECTIOUS DISEASES, 2021, 27 (01) : 150 - 160
  • [6] Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
    Black, S
    Shinefield, H
    Fireman, B
    Lewis, E
    Ray, P
    Hansen, JR
    Elvin, L
    Ensor, KM
    Hackell, J
    Siber, G
    Malinoski, F
    Madore, D
    Chang, I
    Kohberger, R
    Watson, W
    Austrian, R
    Edwards, K
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (03) : 187 - 195
  • [7] CLSI, 2021, Performance standards for antimicrobial susceptibility testing, M100, V31st
  • [8] Efficacy of a pneumococcal conjugate vaccine against acute otitis media
    Eskola, J
    Kilpi, T
    Palmu, A
    Jokinen, J
    Haapakoski, J
    Herva, E
    Takala, A
    Käyhty, H
    Karma, P
    Kohberger, R
    Siber, G
    Mäkela, PH
    Lockhart, S
    Ecrola, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (06) : 403 - 409
  • [9] EUCAST, 2018, EUR COMM ANT SUSC TE
  • [10] Honaker J, 2011, J STAT SOFTW, V45, P1